1-Methylindole-3-carboxylic acid

• Catalog No.: 465313
• CAS Number: 32387-21-6
• M. F.: C10H9NO2
• M. W.: 175.18396
• Purity: 97%

SYNONYMS

• Title: 1-甲基吲哚-3-甲酸
• IUPAC name: 1-methyl-1H-indole-3-carboxylic acid
• IUPAC Traditional name: 1-methylindole-3-carboxylic acid

DATABASE IDS

• CAS Number: 32387-21-6
• PubChem SID: 24870267
• MDL Number: MFCD01321244

PROPERTIES

• Empirical Formula (Hill Notation): C10H9NO2
• Purity: 97%
• Melting Point: 197-200 °C (dec.)(lit.)
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36
• German water hazard class: 3

DETAILS

Description (English)

Packaging
1, 5 g in glass bottle
Application

• Reactant for preparation of bisindolyl pyrimidinones analogs of PKC inhibitor LY3335311
• Reactant for preparation of (heteroaryl)(carboxamido)arylpyrrole derivatives as Cdc7 kinase inhibitors, antitumor and antiproliferative agents2
• Reactant for preparation of (pyrrolidinylmethoxy)cyclohexanecarboxylic acids as antigen-4 (VLA-4) antagonists3
• Reactant for preparation of EphB3 receptor tyrosine kinase inhibitors4
• Reactant for preparation of pyrazolodiazepine derivatives as human P2X7 receptor antagonists5
• Reactant for preparation of potent nonpeptidic urotensin II receptor agonists6
• Reactant for preparation of pyrrolizidine esters, amides, and ureas as 5-HT4 receptor ligands7

Description (简体中文)

包装
1, 5 g in glass bottle
Application

• Reactant for preparation of bisindolyl pyrimidinones analogs of PKC inhibitor LY3335311
• Reactant for preparation of (heteroaryl)(carboxamido)arylpyrrole derivatives as Cdc7 kinase inhibitors, antitumor and antiproliferative agents2
• Reactant for preparation of (pyrrolidinylmethoxy)cyclohexanecarboxylic acids as antigen-4 (VLA-4) antagonists3
• Reactant for preparation of EphB3 receptor tyrosine kinase inhibitors4
• Reactant for preparation of pyrazolodiazepine derivatives as human P2X7 receptor antagonists5
• Reactant for preparation of potent nonpeptidic urotensin II receptor agonists6
• Reactant for preparation of pyrrolizidine esters, amides, and ureas as 5-HT4 receptor ligands7